AFP and hepatocellular carcinoma: Currently, ultrasound and alpha-fetoprotein (AFP) are the preferred monitoring tools for the recurrence of hepatocellular carcinoma, but because of the low specificity, there is still a need to seek more accurate biomarkers to monitor the recurrence of hepatocellular carcinoma and to improve patient survival.